Regen Report https://validator.w3.org/feed/docs/rss2.html Homepage SMSbiotech Receives FDA Clearance for Inhaled Stem Cell Therapy COPD Trial Aspen Neuroscience Publishes Preclinical Data on Parkinson’s iPSC-Derived Cell Therapy Ernexa Therapeutics Reports Positive Preclinical iPSC-Derived Mesenchymal Stem Cell Study, Advances Oncology Strategy Celularity to Manufacture MuseCell Innovations Therapies in the US Novadip Secures €10.4M for Pivotal Phase 3 Bone Repair Cell Therapy Trial New Trial – Autologous Lung Progenitor Cells for COPD Made Scientific Acquires Resilience’s 85K-Square-Foot Cell Therapy Facility Trial – MesenCell Bone Marrow Stem Cells Evaluated in Chronic Graft-Versus-Host Disease Capricor Therapeutics to Present Cardiosphere-Derived Cell Therapy Trial and Open-Label Extension Data at World Muscle Society Congress Kincell Bio and Cellipont Bioservices Merge to Form Kincellis Advanced Therapies Trial – Human Umbilical Cord Mesenchymal Stem Cell Injection Evaluated for Diabetic Nephropathy Cellares and GenomeFrontier Therapeutics Partnering on Automated Virus-Free CAR-T Program for Phase 1 Optics11 Life and Axol Bioscience Improve Standardization and Reproducibility in Cardiac Research Ultragenyx Announces Approval of Fayuvi Gene Therapy for Sanfilippo Syndrome Type A Cord Blood Cells Showed Modest Benefits in Autism Trial Cyllene Therapeutics’ Gene Therapy Receives FDA RMAT Designation for Neurogenic Detrusor Overactivity Novo Nordisk Publishes Results from Embryonic Stem Cell-Derived Dopaminergic Cells for Parkinson’s Phase 1/2 FDA Opens Applications for Expedited IND Pilot Sonoma Biotherapeutics to Automate its Treg Cell Manufacturing Using Cellares’ Cell Shuttle Platform FDA Selects Seven Participants for PreCheck Pilot Program to Advance US Drug Manufacturing Vyriad Begins Mayo Clinic CAR-T Phase 1 for Multiple Myeloma JAX-NYSCF Stem Cell Toolkit for Parkinson’s Disease Longeveron Stem Cell Phase 2b for Hypoplastic Left Heart Syndrome Misses Primary Endpoint ZEO ScientifiX to Expand Umbilical-Cord Stem Cell Offerings to Georgia and Tennessee as New Regenerative Medicine Laws Take Effect Mesenchymal Stem Cell Extracellular Vesicles Reprogram Microglia and Prevent Neurodegeneration in Alzheimer’s Models FDA Clears Colorado University Anschutz’ CAR T-Cell Trial for Colorectal Cancer Longeveron and Miller School Stem Cell Research Advances to Finals of XPRIZE Healthspan for Aging Frailty iPSC-Derived Heart Cells Show Early Promise in Chinese Heart Failure Trial Kolon’s Cell-Based Gene Therapy Fails Phase 3 Osteoarthritis Trial Kangstem Biotech’s Stem Cell for Knee Osteoarthritis Phase 2a Reports Significant Results Webinar: Inside eXmoor’s Cell & Gene GMP Facility, Designed for Uncertainty Aspen Neuroscience Nabs FDA RMAT Designation for its Parkinson’s Cell Therapy Life Biosciences Doses First Patient in Phase 1 of ER‑100 for Optic Neuropathies, Aiming to Rejuvenate Aging Cells CREATE Medicines to Launch First Phase 1/2 In Vivo Trial of CAR-T Candidate CRT-402 for Autoimmune Diseases in Australia Humacyte’s Vascular Tissue Graft Nabs FDA Authorization for 36-Month Shelf Life Guts & Glory: Both of Cynata’s iPSC Trials Flop, GVH Phase 2 and KOA Phase 3 Orca Bio Nabs FDA Approval of TREGZI, its Cell Therapy for Allogeneic Transplant in Adults with Blood Disorders Aspen Neuroscience Completes Cohort 3 and 4 Dosing in iPSC-Derived Phase 1/2a for Parkinson’s FDA Clears AbelZeta’s CAR-T Trial for Progressive MS MEDIPOST Doses First US Patient in Umbilical Cord Stem Cell Therapy for Knee Osteoarthritis Phase 3 Replacing Magnetic Separation with Buoyancy: A Closer Look at Bracco’s New Cell Selection Platform, BubbleGen™ Kenai Therapeutics Completes Enrollment of Phase 1b/2a Parkinson’s iPSC Trial Cell Therapies to Manufacture CAR-T Therapy for Phase 1/2b Solid Tumor Trial in Australia Heartseed Doses First Patient in Historic iPSC-Derived Cardiomyocyte Trial Via Catheter Verismo Therapeutics to Use Cryoport’s IntegriCell® Cryopreservation Services in its Clinical KIR-CAR T Cell Therapy Programs Fate Therapeutics Launches CAR T Trial for Lupus Nephritis CIRM Approves $662M Regen Med Funding, Largest in its History UniXell Biotechnology Nabs IND Clearance for its iPSC Parkinsons Therapy, UX-DA003 Consano Bio’s Platelet-Derived Biologic May Ease Chronic Sciatica, New Study, Advancing RCT